arrow
A

Andrew D. Seidman

Memorial Sloan Kettering Cancer Center
H指数:60
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapyto Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

寡进展性乳腺癌或非小细胞肺癌患者接受或不接受立体定向全身放疗的标准治疗 (巩固使用放射疗法阻断 [遏制] 寡进展): 一项开放标签,随机,对照,2期研究

LANCET
IF88.5
2024-01-0162
OAAI
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+breast cancer leptomeningeal metastases

HER2乳腺癌脑膜转移患者鞘内注射曲妥珠单抗与替代给药途径的HER2-targeted治疗

BREAST
IF7.9
2023-06-0115
OAAI
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging

索拉非尼联合全脑放疗 (WBRT) 治疗乳腺癌脑转移患者的I期试验及flt-pet脑成像的相关研究

2021-06-109
PREAI
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases
2020-06-2767
OAAI